A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh

Yu Chen, Fen Wu, Mengling Liu, Faruque Parvez, Vesna Slavkovich, Mahbub Eunus, Alauddin Ahmed, Maria Argos, Tariqul Islam, Muhammad Rakibuz-Zaman, Rabiul Hasan, Golam Sarwar, Diane Levy, Joseph Graziano, Habibul Ahsan

Research output: Contribution to journalArticle

Abstract

Background: Few prospective studies have evaluated the influence of arsenic methylation capacity on cardiovascular disease (CVD) risk. Objective: We evaluated the association of arsenic exposure from drinking water and arsenic methylation capacity with CVD risk. Method: We conducted a case-cohort study of 369 incident fatal and nonfatal cases of CVD, including 211 cases of heart disease and 148 cases of stroke, and a subcohort of 1,109 subjects randomly selected from the 11,224 participants in the Health Effects of Arsenic Longitudinal Study (HEALS). Results: The adjusted hazard ratios (aHRs) for all CVD, heart disease, and stroke in association with a 1-SD increase in baseline well-water arsenic (112 μg/L) were 1.15 (95% CI: 1.01, 1.30), 1.20 (95%1.04, 1.38), and 1.08 (95%0.90,respectively. aHRs for the second and third tertiles of percentage urinary monomethylarsonic acid (MMA%) relative to the lowest tertile, respectively, were 1.27 (95%0.85, 1.90) and 1.55 (95%1.08, 2.23) for all CVD, and 1.65 (95%1.05, 2.60) and 1.61 (95%1.04, 2.49) for heart disease specifically. The highest versus lowest ratio of urinary dimethylarsinic acid (DMA) to MMA was associated with a significantly decreased risk of CVD (aHR = 0.54; 95%0.34, 0.85) and heart disease (aHR =95%0.33, 0.88). There was no significant association between arsenic metabolite indices and stroke risk. The effects of incomplete arsenic methylation capacity-indicated by higher urinary MMA% or lower urinary DMA%-with higher levels of well-water arsenic on heart disease risk were additive. There was some evidence of a synergy of incomplete methylation capacity with older age and cigarette smoking. Conclusions: Arsenic exposure from drinking water and the incomplete methylation capacity of arsenic were adversely associated with heart disease risk.

Original languageEnglish (US)
Pages (from-to)832-838
Number of pages7
JournalEnvironmental Health Perspectives
Volume121
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

Bangladesh
Arsenic
Methylation
Cardiovascular Diseases
Prospective Studies
Heart Diseases
Cacodylic Acid
Stroke
Drinking Water
Water
Longitudinal Studies
Cohort Studies
Smoking

Keywords

  • Arsenic
  • Arsenic methylation capacity
  • Bangladesh
  • Cardiovascular disease
  • Case-cohort study

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Public Health, Environmental and Occupational Health

Cite this

A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. / Chen, Yu; Wu, Fen; Liu, Mengling; Parvez, Faruque; Slavkovich, Vesna; Eunus, Mahbub; Ahmed, Alauddin; Argos, Maria; Islam, Tariqul; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Levy, Diane; Graziano, Joseph; Ahsan, Habibul.

In: Environmental Health Perspectives, Vol. 121, No. 7, 07.2013, p. 832-838.

Research output: Contribution to journalArticle

Chen, Y, Wu, F, Liu, M, Parvez, F, Slavkovich, V, Eunus, M, Ahmed, A, Argos, M, Islam, T, Rakibuz-Zaman, M, Hasan, R, Sarwar, G, Levy, D, Graziano, J & Ahsan, H 2013, 'A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh', Environmental Health Perspectives, vol. 121, no. 7, pp. 832-838. https://doi.org/10.1289/ehp.1205797
Chen, Yu ; Wu, Fen ; Liu, Mengling ; Parvez, Faruque ; Slavkovich, Vesna ; Eunus, Mahbub ; Ahmed, Alauddin ; Argos, Maria ; Islam, Tariqul ; Rakibuz-Zaman, Muhammad ; Hasan, Rabiul ; Sarwar, Golam ; Levy, Diane ; Graziano, Joseph ; Ahsan, Habibul. / A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. In: Environmental Health Perspectives. 2013 ; Vol. 121, No. 7. pp. 832-838.
@article{63469bb8540a4e1aa94c75e8181430e2,
title = "A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh",
abstract = "Background: Few prospective studies have evaluated the influence of arsenic methylation capacity on cardiovascular disease (CVD) risk. Objective: We evaluated the association of arsenic exposure from drinking water and arsenic methylation capacity with CVD risk. Method: We conducted a case-cohort study of 369 incident fatal and nonfatal cases of CVD, including 211 cases of heart disease and 148 cases of stroke, and a subcohort of 1,109 subjects randomly selected from the 11,224 participants in the Health Effects of Arsenic Longitudinal Study (HEALS). Results: The adjusted hazard ratios (aHRs) for all CVD, heart disease, and stroke in association with a 1-SD increase in baseline well-water arsenic (112 μg/L) were 1.15 (95{\%} CI: 1.01, 1.30), 1.20 (95{\%}1.04, 1.38), and 1.08 (95{\%}0.90,respectively. aHRs for the second and third tertiles of percentage urinary monomethylarsonic acid (MMA{\%}) relative to the lowest tertile, respectively, were 1.27 (95{\%}0.85, 1.90) and 1.55 (95{\%}1.08, 2.23) for all CVD, and 1.65 (95{\%}1.05, 2.60) and 1.61 (95{\%}1.04, 2.49) for heart disease specifically. The highest versus lowest ratio of urinary dimethylarsinic acid (DMA) to MMA was associated with a significantly decreased risk of CVD (aHR = 0.54; 95{\%}0.34, 0.85) and heart disease (aHR =95{\%}0.33, 0.88). There was no significant association between arsenic metabolite indices and stroke risk. The effects of incomplete arsenic methylation capacity-indicated by higher urinary MMA{\%} or lower urinary DMA{\%}-with higher levels of well-water arsenic on heart disease risk were additive. There was some evidence of a synergy of incomplete methylation capacity with older age and cigarette smoking. Conclusions: Arsenic exposure from drinking water and the incomplete methylation capacity of arsenic were adversely associated with heart disease risk.",
keywords = "Arsenic, Arsenic methylation capacity, Bangladesh, Cardiovascular disease, Case-cohort study",
author = "Yu Chen and Fen Wu and Mengling Liu and Faruque Parvez and Vesna Slavkovich and Mahbub Eunus and Alauddin Ahmed and Maria Argos and Tariqul Islam and Muhammad Rakibuz-Zaman and Rabiul Hasan and Golam Sarwar and Diane Levy and Joseph Graziano and Habibul Ahsan",
year = "2013",
month = "7",
doi = "10.1289/ehp.1205797",
language = "English (US)",
volume = "121",
pages = "832--838",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "7",

}

TY - JOUR

T1 - A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh

AU - Chen, Yu

AU - Wu, Fen

AU - Liu, Mengling

AU - Parvez, Faruque

AU - Slavkovich, Vesna

AU - Eunus, Mahbub

AU - Ahmed, Alauddin

AU - Argos, Maria

AU - Islam, Tariqul

AU - Rakibuz-Zaman, Muhammad

AU - Hasan, Rabiul

AU - Sarwar, Golam

AU - Levy, Diane

AU - Graziano, Joseph

AU - Ahsan, Habibul

PY - 2013/7

Y1 - 2013/7

N2 - Background: Few prospective studies have evaluated the influence of arsenic methylation capacity on cardiovascular disease (CVD) risk. Objective: We evaluated the association of arsenic exposure from drinking water and arsenic methylation capacity with CVD risk. Method: We conducted a case-cohort study of 369 incident fatal and nonfatal cases of CVD, including 211 cases of heart disease and 148 cases of stroke, and a subcohort of 1,109 subjects randomly selected from the 11,224 participants in the Health Effects of Arsenic Longitudinal Study (HEALS). Results: The adjusted hazard ratios (aHRs) for all CVD, heart disease, and stroke in association with a 1-SD increase in baseline well-water arsenic (112 μg/L) were 1.15 (95% CI: 1.01, 1.30), 1.20 (95%1.04, 1.38), and 1.08 (95%0.90,respectively. aHRs for the second and third tertiles of percentage urinary monomethylarsonic acid (MMA%) relative to the lowest tertile, respectively, were 1.27 (95%0.85, 1.90) and 1.55 (95%1.08, 2.23) for all CVD, and 1.65 (95%1.05, 2.60) and 1.61 (95%1.04, 2.49) for heart disease specifically. The highest versus lowest ratio of urinary dimethylarsinic acid (DMA) to MMA was associated with a significantly decreased risk of CVD (aHR = 0.54; 95%0.34, 0.85) and heart disease (aHR =95%0.33, 0.88). There was no significant association between arsenic metabolite indices and stroke risk. The effects of incomplete arsenic methylation capacity-indicated by higher urinary MMA% or lower urinary DMA%-with higher levels of well-water arsenic on heart disease risk were additive. There was some evidence of a synergy of incomplete methylation capacity with older age and cigarette smoking. Conclusions: Arsenic exposure from drinking water and the incomplete methylation capacity of arsenic were adversely associated with heart disease risk.

AB - Background: Few prospective studies have evaluated the influence of arsenic methylation capacity on cardiovascular disease (CVD) risk. Objective: We evaluated the association of arsenic exposure from drinking water and arsenic methylation capacity with CVD risk. Method: We conducted a case-cohort study of 369 incident fatal and nonfatal cases of CVD, including 211 cases of heart disease and 148 cases of stroke, and a subcohort of 1,109 subjects randomly selected from the 11,224 participants in the Health Effects of Arsenic Longitudinal Study (HEALS). Results: The adjusted hazard ratios (aHRs) for all CVD, heart disease, and stroke in association with a 1-SD increase in baseline well-water arsenic (112 μg/L) were 1.15 (95% CI: 1.01, 1.30), 1.20 (95%1.04, 1.38), and 1.08 (95%0.90,respectively. aHRs for the second and third tertiles of percentage urinary monomethylarsonic acid (MMA%) relative to the lowest tertile, respectively, were 1.27 (95%0.85, 1.90) and 1.55 (95%1.08, 2.23) for all CVD, and 1.65 (95%1.05, 2.60) and 1.61 (95%1.04, 2.49) for heart disease specifically. The highest versus lowest ratio of urinary dimethylarsinic acid (DMA) to MMA was associated with a significantly decreased risk of CVD (aHR = 0.54; 95%0.34, 0.85) and heart disease (aHR =95%0.33, 0.88). There was no significant association between arsenic metabolite indices and stroke risk. The effects of incomplete arsenic methylation capacity-indicated by higher urinary MMA% or lower urinary DMA%-with higher levels of well-water arsenic on heart disease risk were additive. There was some evidence of a synergy of incomplete methylation capacity with older age and cigarette smoking. Conclusions: Arsenic exposure from drinking water and the incomplete methylation capacity of arsenic were adversely associated with heart disease risk.

KW - Arsenic

KW - Arsenic methylation capacity

KW - Bangladesh

KW - Cardiovascular disease

KW - Case-cohort study

UR - http://www.scopus.com/inward/record.url?scp=84879570008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879570008&partnerID=8YFLogxK

U2 - 10.1289/ehp.1205797

DO - 10.1289/ehp.1205797

M3 - Article

VL - 121

SP - 832

EP - 838

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 7

ER -